-
1
المؤلفون: Serge Guyétant, Jürgen Behr, Yves Courty, Kristina A. M. Arendt, Agnès Petit-Courty, Sylvain Marchand-Adam, Valérie Gissot, Anne-Sophie Lamort, Ina Koch, Jan‐Christian Kaiser, Georgios T. Stathopoulos, Ioanna Giopanou, Maria Oplopoiou, Michael Lindner, Ioannis Lilis, Martin E. Eichhorn, Rudolf Hatz, Giannoula Ntaliarda, Mario A.A. Pepe, Laura V. Klotz, Anja Stowasser, Alicia Morresi-Hauf, Sabine J. Behrend
المساهمون: Ludwig Maximilians University of Munich, German Center for Lung Research, Comprehensive pneumology center, Partenaires INRAE, University Hospital, German Centre for Lung Research, Institut National de la Santé et de la Recherche Médicale (INSERM), University-Hospital Munich-Großhadern [München], Heidelberg University, University of Patras, Alexander Fleming Biomedical Sciences Research Center, Asklepios Medical Center, Infectiologie et Santé Publique (UMR ISP), Institut National de la Recherche Agronomique (INRA)-Université de Tours, Centre Hospitalier Régional Universitaire de Tours (CHRU de Tours), Asklepios Lung Clinic Gauting, German Research Center for Environmental Health - Helmholtz Center München (GmbH), Institut National de la Recherche Agronomique (INRA)-Université de Tours (UT), Ludwig-Maximilians University [Munich] (LMU), ProdInra, Migration
المصدر: Cancer Medicine
Cancer Medicine, Vol 8, Iss 4, Pp 1486-1499 (2019)
Cancer Medicine, Wiley, 2019, 8 (4), pp.1486-1499. ⟨10.1002/cam4.2031⟩
Cancer Med. 8, 1486-1499 (2019)
Cancer Medicine (8), 1486-1499. (2019)
Cancer Medicine, 2019, 8 (4), pp.1486-1499. ⟨10.1002/cam4.2031⟩مصطلحات موضوعية: 0301 basic medicine, Research design, Male, Cancer Research, Lung Neoplasms, Death risk, Pneumologie et système respiratoire, LADC, lung adenocarcinoma, obstruction, smoking, survival, Pulmonary Surgical Procedures, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, 0302 clinical medicine, Recurrence, Germany, Medicine, Prospective Studies, Cancer, Original Research, Curative intent, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, résection, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Cohort, Adenocarcinoma, Female, Lung resection, medicine.medical_specialty, adénocarcinome, Médecine humaine et pathologie, [SDV.CAN]Life Sciences [q-bio]/Cancer, Adenocarcinoma of Lung, lcsh:RC254-282, Time-to-Treatment, 03 medical and health sciences, FEV1/FVC ratio, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, Humans, tabagisme, Radiology, Nuclear Medicine and imaging, Mortality, Pulmonology and respiratory tract, Aged, Neoplasm Staging, Lung, business.industry, Clinical Cancer Research, medicine.disease, 030104 developmental biology, poumon, [SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Human health and pathology, Ladc, Lung Adenocarcinoma, Obstruction, Smoking, Survival, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::538912edf61ad5834f776290fbba5d74Test
http://europepmc.org/articles/PMC6488114Test -
2
المؤلفون: Bruno Pereira, Frédéric Costes, Denis Caillaud, Vivien Reynaud, Emmanuel Coudeyre, Ruddy Richard, Annick Greil, Daniela Muti
المساهمون: Service Médecine du Sport et Explorations Fonctionnelles [CHU Clermont-Ferrand], CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand-CHU Estaing [Clermont-Ferrand], CHU Clermont-Ferrand, Service Médecine physique et de réadaptation [CHU Toulouse], Pôle Neurosciences [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Pôle Santé publique et médecine publique [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Service de Pneumologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Hôtel Dieu, Clinique Cardio Pneumologique, Biostatistiques, Danone Research, Unité de Nutrition Humaine (UNH), Institut National de la Recherche Agronomique (INRA)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Centre de Recherche en Nutrition Humaine, Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Service de Médecine du Sport et des Explorations Fonctionnelles, Service de Médecine Physique et Réadaptation, CHU Toulouse [Toulouse]-Hôpital de Rangueil, CHU Toulouse [Toulouse], Reynaud, Vivien, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Hôtel Dieu, Unité de Nutrition Humaine - Clermont Auvergne (UNH), Institut National de la Recherche Agronomique (INRA)-Université Clermont Auvergne (UCA), Université Clermont Auvergne (UCA)
المصدر: Journal of Clinical Medicine
Journal of Clinical Medicine, 2019, 8 (10), ⟨10.3390/jcm8101752⟩
Journal of Clinical Medicine, MDPI, 2019, 8 (10), ⟨10.3390/jcm8101752⟩
Journal of Clinical Medicine 10 (8), . (2019)
Volume 8
Issue 10
Journal of Clinical Medicine, Vol 8, Iss 10, p 1752 (2019)مصطلحات موضوعية: medicine.medical_specialty, Copd patients, Pneumologie et système respiratoire, Pulmonary disease, lcsh:Medicine, Médecine humaine et pathologie, Timed Up and Go test, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Article, 03 medical and health sciences, 0302 clinical medicine, Fall, Medicine, 030212 general & internal medicine, Risk factor, Hypoxia, Pulmonology and respiratory tract, COPD, Chronic obstructive pulmonary disease, Postural balance, business.industry, lcsh:R, General Medicine, Fall risk, medicine.disease, Clinical Practice, 030228 respiratory system, Berg Balance Scale, Physical therapy, Human health and pathology, business, human activities, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8637818725e82a4e25dc6aa62ddc4a02Test
https://hal.science/hal-02352492Test -
3
المؤلفون: Frédéric Costes, Léonard Féasson, Mathieu Berger, Isabelle Court Fortune, Samuel Verges, Pierre Labeix
المساهمون: Physiologie Clinique et Exercice, Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), EA 7424, Laboratoire Interuniversitaire Biologie Motricité, Université de Lyon, Université Jean Monnet - Saint-Étienne (UJM), Système Nerveux Autonome, Epidémiologie, Physiologie, Ingénierie, Santé (SNA- EPIS), Pneumologie & Oncologie Thoracique, HP2 Laboratoire d'Hypoxie et Physiopathologie Cardiovasculaire et Respiratoire, Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Grenoble, Unité de Nutrition Humaine (UNH), Institut National de la Recherche Agronomique (INRA)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Médecine du Sport et Explorations Fonctionnelles, CHU Clermont-Ferrand, Association Lyonnaise de Logistique Posthospitaliere, Lyon, France, Costes, Frédéric, ProdInra, Archive Ouverte, Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne), Université Jean Monnet (Saint-Etienne), Unité de Nutrition Humaine - Clermont Auvergne (UNH), Institut National de la Recherche Agronomique (INRA)-Université Clermont Auvergne (UCA), Centre Hospitalier Universitaire de Clermont-Ferrand
المصدر: International Journal of Chronic Obstructive Pulmonary Disease
International Journal of Chronic Obstructive Pulmonary Disease, 2019, 14, pp.2461-2468. ⟨10.2147/copd.s216347⟩
International Journal of Chronic Obstructive Pulmonary Disease (14), 2461-2468. (2019)
International Journal of COPD, Vol Volume 14, Pp 2461-2468 (2019)
International Journal of Chronic Obstructive Pulmonary Disease, Dove Medical Press, 2019, 14, pp.2461-2468. ⟨10.2147/copd.s216347⟩مصطلحات موضوعية: Male, Time Factors, Copd patients, medicine.medical_treatment, Pneumologie et système respiratoire, Severity of Illness Index, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Quadriceps Muscle, law.invention, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Randomized controlled trial, law, 030212 general & internal medicine, Respiratory system, Lung, Original Research, endurance, COPD, Exercise Tolerance, exercise, non-invasive ventilation, General Medicine, Middle Aged, Exercise Therapy, 3. Good health, Treatment Outcome, Breathing, Cardiology, Female, Cycling, Moderate to severe, medicine.medical_specialty, limb muscle, macromolecular substances, International Journal of Chronic Obstructive Pulmonary Disease, 03 medical and health sciences, Internal medicine, medicine, Humans, Pulmonary rehabilitation, Pulmonology and respiratory tract, Aged, lcsh:RC705-779, Noninvasive Ventilation, business.industry, copd, Recovery of Function, lcsh:Diseases of the respiratory system, medicine.disease, Bicycling, respiratory tract diseases, 030228 respiratory system, non invasive ventilation, [SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, business
وصف الملف: application/pdf; text/html
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1e76c6ed98a9ab83be8aaa886ae95b0Test
https://hal.science/hal-02396247Test -
4
المؤلفون: Laurie Pahus, Pierre-Régis Burgel, Nicolas Roche, Jean-Louis Paillasseur, Pascal Chanez, on behalf of Initiatives BPCO scientific committee
المساهمون: Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Anthropologie bio-culturelle, Droit, Ethique et Santé (ADES), Aix Marseille Université (AMU)-EFS ALPES MEDITERRANEE-Centre National de la Recherche Scientifique (CNRS), Centre d'Investigation Clinique Pédiatrique [Marseille], Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital d'Enfants de la Timone [Marseille], Assistance Publique - Hôpitaux de Marseille (APHM)-Assistance Publique - Hôpitaux de Marseille (APHM), Université Paris Descartes - Paris 5 (UPD5), AP-HP Hôpitaux Universitaires Paris Centre, EFFI-STAT
المصدر: BMC Pulmonary Medicine (19), . (2019)
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-11 (2019)
BMC Pulmonary Medicine
BMC Pulmonary Medicine, 2019, 19, ⟨10.1186/s12890-019-0882-y⟩
BMC Pulmonary Medicine, BioMed Central, 2019, 19, ⟨10.1186/s12890-019-0882-y⟩مصطلحات موضوعية: Exacerbation, Pneumologie et système respiratoire, Severity of Illness Index, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, law.invention, Clinical research, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Randomized controlled trial, law, Forced Expiratory Volume, Medicine, 030212 general & internal medicine, Randomized Controlled Trials as Topic, COPD, education.field_of_study, Evidence-Based Medicine, essai randomisé contrôlé, 3. Good health, Bronchodilator Agents, maladie pulmonaire, External validity, COPD exacerbations, Cohort, Disease Progression, patient, Research Article, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Population, 03 medical and health sciences, Humans, tabagisme, education, Intensive care medicine, Pulmonology and respiratory tract, lcsh:RC705-779, traitement pharmacologique, business.industry, Patient Selection, Reproducibility of Results, Evidence-based medicine, lcsh:Diseases of the respiratory system, medicine.disease, Clinical trial, 030228 respiratory system, Quality of Life, Diffusion of Innovation, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e8ae67f597ec8ec7d792f826589e778Test
http://prodinra.inra.fr/record/479517Test -
5
المؤلفون: Vincent Cottin
المساهمون: Rétrovirus et Pathologie Comparée, Institut National de la Recherche Agronomique (INRA)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon, Hospices Civils de Lyon (HCL)
المصدر: European Respiratory Review, Vol 24, Iss 138, Pp 547-549 (2015)
European Respiratory Review
European Respiratory Review, European Respiratory Society, 2015, 24 (138), pp.547-549. ⟨10.1183/16000617.0070-2015⟩
European Respiratory Review 138 (24), 547-549. (2015)مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Biomedical Research, MEDLINE, Pneumologie et système respiratoire, Review Literature as Topic, 030204 cardiovascular system & hematology, Bibliometrics, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Access to Information, 03 medical and health sciences, 0302 clinical medicine, Pulmonary medicine, Pulmonary Medicine, medicine, Humans, Respiratory system, Intensive care medicine, Pulmonology and respiratory tract, ComputingMilieux_MISCELLANEOUS, lcsh:RC705-779, business.industry, lcsh:Diseases of the respiratory system, 3. Good health, Access to information, maladie respiratoire, 030228 respiratory system, Periodicals as Topic, business, Editorial Policies, Forecasting
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00bd110ff7ac4a7ffc7aaf082d67e638Test
http://err.ersjournals.com/content/24/138/547.fullTest -
6
المؤلفون: Harold R. Collard, Marc Humbert, Carlo Vancheri, Marco Matucci-Cerinic, Gérald Simonneau, Athol U. Wells, Sergio Harari, Vincent Cottin, Francesco Blasi
المساهمون: Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, UO Pneumol, Faculté de Médecine, Université Paris Sud (Paris 11), Centre de Référence de l’Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Service de Pneumologie, Hôpital Bicêtre, Assistance Publique - Hôpitaux de Paris (AP-HP), INSERM, UMR_S 999, Laboratoire d’Excellence (LabEx) en Recherche sur le Médicament et l’Innovation Thérapeutique (LERMIT), Department of Pathophysiology and Transplantation, University of Milan, University of California [San Francisco] (UCSF), University of California, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, School of Medicine, University of Florence (UNIFI), Department of Clinical and Experimental Biomedicine, Section of Respiratory Diseases, Regional Center for Interstitial and Rare Lung Diseases, Università degli Studi di Catania (UniCT), Royal Brompton and Harefield NHS Foundation Trust, Rétrovirus et Pathologie Comparée (RPC), Institut National de la Recherche Agronomique (INRA)-École pratique des hautes études (EPHE)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Ecole Nationale Vétérinaire de Lyon (ENVL), Service de Pneumologie, Centre de Référence National des Maladies Pulmonaires Rares, Hospices Civils de Lyon (HCL), Università degli Studi di Firenze = University of Florence [Firenze] (UNIFI), Institut National de la Recherche Agronomique (INRA)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Claude Bernard Lyon 1 (UCBL), ProdInra, Archive Ouverte, Università degli Studi di Milano = University of Milan (UNIMI), University of California [San Francisco] (UC San Francisco), University of California (UC), Università degli Studi di Firenze = University of Florence (UniFI), Università degli studi di Catania = University of Catania (Unict)
المصدر: European Respiratory Review
European Respiratory Review, European Respiratory Society, 2015, 24 (137), pp.375-377. ⟨10.1183/16000617.0051-2015⟩
European Respiratory Review, Vol 24, Iss 137, Pp 375-377 (2015)
European Respiratory Review 137 (24), 375-377. (2015)
European Respiratory Review, 2015, 24 (137), pp.375-377. ⟨10.1183/16000617.0051-2015⟩
European respiratory review : an official journal of the European Respiratory Society, vol 24, iss 137مصطلحات موضوعية: Lung Diseases, Biomedical Research, Orphan Drug Production, rare disease/diagnosis/drug therapy/physiopathology, Medical Physiology, Respiratory System, lung/drug effects, Respiratory System Agents, Pneumologie et système respiratoire, chemotherapy, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, pathologie, Lung, appareil urinaire, Pediatric, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, 3. Good health, maladie pulmonaire, medicine.anatomical_structure, Respiratory, lung disease/diagnosis, biomedical research/trends, Pulmonary and Respiratory Medicine, medicine.medical_specialty, endocrine system, Chronic Obstructive Pulmonary Disease, education, physiopathologie, Médecine humaine et pathologie, forecasting, respiratory system agents/therapeutic use, Orphan drug, Rare Diseases, medicine, Humans, respiratory system diseases, human, Intensive care medicine, thérapeutique médicamenteuse, Pulmonology and respiratory tract, lcsh:RC705-779, business.industry, appareil respiratoire, lcsh:Diseases of the respiratory system, respiratory tract, Orphan Drug, orphan drug production, [SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Human health and pathology, urinary system, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, Forecasting
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf78bbe82b3aaf75cdd312ea7257e041Test
https://hal.archives-ouvertes.fr/hal-01600222Test -
7
المؤلفون: Ingrid Guiffard, Jérôme Abadie, Sabine Sévère, Philippe Marchand, Floriane Morio, Jean-Philippe Antignac, Anaïs Vénisseau, Bruno Le Bizec, Bruno Veyrand
المساهمون: Laboratoire d'étude des Résidus et Contaminants dans les Aliments (LABERCA), Institut National de la Recherche Agronomique (INRA)-Ecole Nationale Vétérinaire, Agroalimentaire et de l'alimentation Nantes-Atlantique (ONIRIS), LUNAM Université [Nantes Angers Le Mans], Sévère, Sabine
المصدر: SpringerPlus
SpringerPlus, SpringerOpen, 2015, 4, pp.27. ⟨10.1186/s40064-015-0790-4⟩
SpringerPlus (4), 27. (2015)مصطلحات موضوعية: medicine.medical_specialty, Etiology, polluant organique persistant, Pneumologie et système respiratoire, Dog model, Context (language use), Disease, Bioinformatics, Ecotoxicologie, Ecotoxicology, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Pathogenesis, Breast cancer, Epidemiology, animal modèle, Medicine, cancer du poumon, pathogénèse, Pulmonology and respiratory tract, Aryl hydrocarbon receptor, Multidisciplinary, Comparative oncology, business.industry, facteur environnemental, Research, Persistent organic pollutants, Cancer, medicine.disease, substance toxique, 3. Good health, 13. Climate action, oncologie, chien, [SDV.TOX.ECO]Life Sciences [q-bio]/Toxicology/Ecotoxicology, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7259c534fa10e296e46333b6acfd8fd9Test
https://hal.inrae.fr/hal-02637908/documentTest -
8
المؤلفون: Alexandre Belot, Isabelle Durieu, Nicole Fabien, Jean-Christophe Lega, Quitterie Reynaud, Vincent Cottin
المساهمون: Service de Médecine Interne Vasculaire, Hospices Civils de Lyon (HCL), Evaluation et modélisation des effets thérapeutiques, Département biostatistiques et modélisation pour la santé et l'environnement [LBBE], Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS), Department of Pathology, Hôpital Femme-Mère-Enfant, Département Immunologie (DéPARTEMENT IMMUNOLOGIE), Rétrovirus et Pathologie Comparée (RPC), Institut National de la Recherche Agronomique (INRA)-École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Ecole Nationale Vétérinaire de Lyon (ENVL), Institut National de la Recherche Agronomique (INRA)-École pratique des hautes études (EPHE), Institut National de la Recherche Agronomique (INRA)-École pratique des hautes études (EPHE)-Université Claude Bernard Lyon 1 (UCBL)
المصدر: European Respiratory Review 136 (24), 216-238. (2015)
European Respiratory Review, Vol 24, Iss 136, Pp 216-238 (2015)
European Respiratory Review
European Respiratory Review, 2015, 24 (136), pp.216-238. ⟨10.1183/16000617.00002015⟩
European Respiratory Review, European Respiratory Society, 2015, 24 (136), pp.216-238. ⟨10.1183/16000617.00002015⟩مصطلحات موضوعية: Pathology, Time Factors, Pneumologie et système respiratoire, morbidity, Comorbidity, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, 0302 clinical medicine, Risk Factors, morbidité, Lung, maladie inflammatoire, Myositis, Interstitial lung disease, respiratory system, Prognosis, 3. Good health, inflammatory disease, maladie pulmonaire, medicine.anatomical_structure, Disease Progression, Drug Therapy, Combination, Immunosuppressive Agents, myopathy, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Malignancy, 03 medical and health sciences, Pleural disease, Predictive Value of Tests, medicine, Animals, Humans, respiratory system diseases, Pulmonology and respiratory tract, Autoantibodies, myopathie, 030203 arthritis & rheumatology, lcsh:RC705-779, business.industry, lcsh:Diseases of the respiratory system, Dermatomyositis, medicine.disease, mortality, 030228 respiratory system, Inclusion body myositis, business, Lung Diseases, Interstitial, mortalité, Biomarkers
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e51a75a2d0dbc2f58aa385654c401cddTest
http://prodinra.inra.fr/record/396170Test -
9
المساهمون: Rétrovirus et Pathologie Comparée (RPC), Institut National de la Recherche Agronomique (INRA)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Ecole Nationale Vétérinaire de Lyon (ENVL), Cottin, Vincent, Infections Virales et Pathologie Comparée - UMR 754 (IVPC), Institut National de la Recherche Agronomique (INRA)-École pratique des hautes études (EPHE)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon
المصدر: Orphanet journal of rare diseases
Orphanet journal of rare diseases, 2014, 9, pp.191. ⟨10.1186/s13023-014-0191-8⟩
Orphanet Journal of Rare Diseases (9), 1-8. (2014)
Orphanet Journal of Rare Diseases, vol. 9, no. 1, pp. 191
Orphanet Journal of Rare Diseasesمصطلحات موضوعية: Lung Diseases, Male, [SDV]Life Sciences [q-bio], Pneumologie et système respiratoire, Gastroenterology, Langerhans cell granulomatosis, Langerhans cell histiocytosis, Chlorodeoxyadenosine, Genetics(clinical), Pharmacology (medical), Cladribine, Genetics (clinical), Medicine(all), Smoking, Cladribine/*therapeutic use, General Medicine, Middle Aged, Lung Diseases/*diagnosis/*drug therapy/etiology, Smoking/adverse effects/drug therapy, Antineoplastic Agents/*therapeutic use, 3. Good health, Histiocytosis, medicine.anatomical_structure, Treatment Outcome, Female, Langerhans-Cell/complications/*diagnosis/*drug therapy, medicine.drug, Adult, histiocytose X, medicine.medical_specialty, histiocytosis, langerhans cell granulomatosis, cladribine, chlorodeoxyadenosine, pulmonary hypertension, Antineoplastic Agents, Pulmonary hypertension, Internal medicine, medicine, hypertension pulmonaire, Humans, Pulmonology and respiratory tract, Histiocyte, Retrospective Studies, Lung, business.industry, Research, medicine.disease, Histiocytosis, Langerhans-Cell, Pneumonia, Immunology, business, Progressive disease
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39ceee6d135e6f4c820a1085a23056cTest
https://hal-univ-lyon1.archives-ouvertes.fr/hal-02192909Test -
10
المؤلفون: James Ferguson, Pieter Dewint, Richard Groves, Alexandre Sarafidis, Carlo Vancheri, Jim J. Egan, Per M. Hellström, Michael Kreuter, Maria Molina-Molina, Toby M. Maher, Vincent Cottin, Klas Nordlind, Ulrich Costabel, Elisabeth Bendstrup
المساهمون: Costabel, Ulrich, University of Duisburg-Essen, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital [Gothenburg], Rétrovirus et Pathologie Comparée, Institut National de la Recherche Agronomique (INRA)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Ecole Nationale Vétérinaire de Lyon (ENVL)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS), Erasmus University Rotterdam, Mater Misericordiae University Hospital, Ninewells Hospital, King‘s College London, Uppsala University, Heidelberg University, Respiratory Critical Care Medicine Heidelberg, Partenaires INRAE, Royal Brompton Hospital, Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), University Hospital, Centre Hospitalier Interrégional Edith Cavell (CHIREC), Università degli Studi di Catania (UniCT), InterMune International AG, Basel, Switzerland.
المصدر: Advances in Therapy 4 (31), 375-391. (2014)
Advances in Therapy
Advances in Therapy, Springer Verlag (Germany), 2014, 31 (4), pp.375-391. ⟨10.1007/s12325-014-0112-1⟩
Costabel, U, Bendstrup, E, Cottin, V, Dewint, P, Egan, J J J, Ferguson, J, Groves, R, Hellström, P M, Kreuter, M, Maher, T M, Molina-Molina, M, Nordlind, K, Sarafidis, A & Vancheri, C 2014, ' Pirfenidone in idiopathic pulmonary fibrosis : Expert panel discussion on the management of drug-related adverse events ', Advances in Therapy, vol. 31, no. 4, pp. 375-391 . https://doi.org/10.1007/s12325-014-0112-1Testمصطلحات موضوعية: photosensibilité, Alternative medicine, Medizin, Pneumologie et système respiratoire, Review, Pharmacology, Pharmacologie, Pirfenidone, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Idiopathic pulmonary fibrosis, 0302 clinical medicine, Adverse event management, Photosensitivity, Medicine, Pharmacology (medical), 030212 general & internal medicine, Disease management (health), General Clinical Medicine, media_common, Medicine(all), Anti-Inflammatory Agents, Non-Steroidal, adverse event management, Disease Management, General Medicine, Farmakologi och toxikologi, idiopathic pulmonary fibrosis, 3. Good health, Respiratory Function Tests, expert opinion, Expert opinion, Respiratory, expertise, Safety, medicine.drug, Drug, safety, medicine.medical_specialty, fibrose pulmonaire, Drug-Related Side Effects and Adverse Reactions, Pyridones, media_common.quotation_subject, MEDLINE, photosensitivity, Pharmacology and Toxicology, Disease-Free Survival, 03 medical and health sciences, Humans, gastrointestinal events, Intensive care medicine, Adverse effect, Pulmonology and respiratory tract, Panel discussion, business.industry, Tumor Necrosis Factor-alpha, Gastrointestinal events, Skin-related events, medicine.disease, respiratory, 030228 respiratory system, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, pirfenidone, skin-related events, 1115 Pharmacology And Pharmaceutical Sciences, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e831a73499517417d65a6014b8b6b6a3Test
http://prodinra.inra.fr/record/307378Test